Status:

UNKNOWN

Platelet-rich Plasma for Menical Tear

Lead Sponsor:

University of Malaga

Conditions:

Platelet-Rich Plasma

Meniscus Lesion

Eligibility:

All Genders

18-60 years

Brief Summary

Meniscal injuries are a common pathology among athletes, and have an impact on the daily or sporting practice of patients. Surgical approach implies sometimes heavy consequences. Platelet-rich-plasma ...

Eligibility Criteria

Inclusion

  • Skeletally mature patients 18-70 years of age
  • With diagnosis of meniscus injury
  • Single tear of the medial and/or lateral meniscus
  • With no indication of meniscus repair surgery

Exclusion

  • Prior history of multiple ligaments injury, associated significant ligament instability: Grade III MCL, Grade III PCL, or ACL deficient knee
  • Prior history of knee surgery
  • Discoid meniscus
  • Osteoarthritic changes (Kellgren Lawrence scale \>2)
  • Inflammatory diseases (i.e. rheumatoid arthritis)
  • Underlying bleeding disorder or coagulopathy
  • Concominant chondral defects (\> 2 ICRS)
  • Cancer patients
  • Pregnancy
  • Patients who will not cooperate with six-month followup

Key Trial Info

Start Date :

January 1 2014

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

November 1 2019

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT04040283

Start Date

January 1 2014

End Date

November 1 2019

Last Update

July 31 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ivan Medina-Porqueres

Málaga, Spain

Platelet-rich Plasma for Menical Tear | DecenTrialz